Şunu aradınız:: thrombophilic (İngilizce - Maltaca)

16 patients with a history of vte or known thrombophilic states have an increased risk of vte.
pazjenti b' passat ta 'vte jew stati trombofiliċi magħrufa għandhom riskju ikbar ta' vte.

patients with known thrombophilic states have an increased risk of vte and hormone therapy may add to this risk.
pazjenti li għandhom stati trombofiliċi magħrufin għandhom riskju miżjud ta’ vte u t-terapija bl- ormoni tista’ żżid ma’ dan ir-riskju.

personal or strong family history of thromboembolism, or recurrent spontaneous abortion, should be investigated in order to exclude a thrombophilic predisposition.
storja personali jew storja b' saħħitha tal- familja ta 'trombo - emboliżmu, jew abort spontanju rikorrenti, għandha tiġi investigata sabiex tiġi eskluża predispożizzjoni trombofilika.

known thrombophilic disorders (e.g., protein c, protein s, or antithrombin deficiency, see section 4.4).
disturbi trombofiliċi magħrufa (eż. nuqqas ta’ proteina Ċ, proteina s jew antitrombini, ara sezzjoni 4.4).

caution should be exercised in prescribing and infusing ivig in obese patients and in patients with pre-existing risk factors for thrombotic events (such as advanced age, hypertension, diabetes mellitus and a history of vascular disease or thrombotic episodes, patients with acquired or inherited thrombophilic disorders, patients with prolonged periods of immobilisation, severely hypovolemic patients, and patients with diseases which increase blood viscosity).
għandha tingħata attenzjoni meta tingħata riċetta u waqt l-infużjuni ta’ ivig lil pazjenti ħoxnin, u f’pazjenti b’fatturi ta’ riskju li kienu jeżistu minn qabel għal avvenimenti trombotiċi (bħal età avvanzata, pressjoni tad-demm għolja, dijabete mellitus u storja medika ta’ mard vaskulari jew episodji trombotiċi, pazjenti b’disturbi trombofiliċi miksuba jew li ntirtu, pazjenti li jqattgħu perjodi twal ma jitħarrkux, pazjenti li huma ipovolemiċi b’mod sever, u pazjenti b’mard li jżid il-viskosità tad-demm).